5 reports

  • Namenda (memantine)

Triptans have been dominating the anti-migraine market, however of late managed care is promoted to limit the use of triptans, due to their side-effect profile.

  • Antipsychotic
  • Hospital
  • AstraZeneca PLC
  • Lilly Endowment Inc.
  • Pfizer Inc.
  • 4. DRUG/MOLECULE REFERS TO PRIMARY INTERVENTION ONLY.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Antipsychotic
  • Drug Development
  • Pharmaceutical
  • World
  • Product Initiative
  • 5. All the trials included are unique trials.

## ## ## ## ## ## ## ## China ## ## ## ## ## ## ## ## Russia ## ## ## ## ## ## ## ## Brazil ## ## ## ## ## ## ## ## Mexico ## ## ## ## ## ## ## ## Turkey Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are ta

  • Antipsychotic
  • Clinical Trial
  • Psychotic Disorder
  • Therapy
  • World

Indomethacin targets prostaglandin G/ H synthase ## and ## (COX-## and -##).

  • Antipsychotic
  • Pharmaceutical
  • United States
  • Company Operations
  • NAL Pharma
  • 6.18.6. ZOLMITRIPTAN SALES
  • DEPICTS THE TOTAL ZOLMITRIPTAN SALES FOR THE PERIOD 2010-2012.

IT IS ONE OF THE MOST EFFICIENT OF TRIPTANS AND PROVIDES RAPID ONSET OF ACTION.

  • Antipsychotic
  • North America
  • United States
  • Demand
  • Market Size